CTRI/2024/01/061644
Not yet recruiting
Phase 2
Comparison of efficacy of intranasal versus intravenous midazolam in acute seizure control in children - NI
Government medical college and hospital, Chandigarh0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: G969- Disorder of central nervous system, unspecified
- Sponsor
- Government medical college and hospital, Chandigarh
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All children between the ages of 1 month and 18 years presenting with acute seizures for at least 5 minutes duration in pediatric emergency and in patient department of GMCH 32, Chandigarh
Exclusion Criteria
- •1\) Non consenting parents
- •2\) Children \<5kg weight
- •3\) Children with upper respiratory tract infections
- •4\) Children who had received anticonvulsants within 1 hour before admission
- •5\) Children with severe cardiorespiratory decompensation
- •6\) Children with CSF rhinorrhea
- •7\) Known allergy to benzodiazepines.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparison of intranasal administration with intravenous injection of dexmedetomidine in postoperative pain control of mandibular fracturesPain intensity.Acute pain due to traumaG89.11IRCT20190325043107N40Tabriz University of Medical Sciences70
Recruiting
Phase 3
A clinical trial to study the effects of nasal and venous dexmetomidine on change of blood pressure and heart rate during anaesthesia in lumber spine surgeryHealth Condition 1: null- elective lumber spine surgery.CTRI/2018/03/012556Bangur Institute of Neurosciences
Active, not recruiting
Not Applicable
Comparative efficacy and safety of two intranasal Triamcinolone Acetonide formulations in persistent allergic rhinitisPersistent allergic rhinitisEUCTR2005-002742-19-GBeolab Limited24
Recruiting
Phase 2
Effect of budesonide, montelukast and their combination in allergic rhinitisAllergic rhinitis.Vasomotor and allergic rhinitisIRCT20171030037093N41Esfahan University of Medical Sciences135
Active, not recruiting
Phase 1
Comparative Efficacy & Safety of Two Intranasal Fluticasone Propionate Formulations in Persistent Allergic Rhinitis - N/APersistent allergic rhinitisEUCTR2005-001297-27-GBeolab td22